Dr. John Michael Pagel, MD, PhD
- Medicare services, 2021
- 413
- Part D claims, 2022
- 56
- Publications
- 148
- Clinical trials
- 7
- Industry payments
- $1.5M
- Practice address
- 747 Broadway, Seattle, WA 98122
- Practice phone
- Call (206) 386-6000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Swedish Medical Center -First Hill
Seattle, Washington
Find Dr. Pagel's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. John Michael Pagel is a hematologist and oncologist in Seattle, Washington
Dr. Pagel practices at Swedish Medical Center -First Hill in Seattle, Washington.
Dr. Pagel's NPI, 1376633222, was assigned on October 13, 2006. Dr. Pagel graduated from Boston University School of Medicine in 1996. Dr. Pagel holds Washington license MD00037306.
- NPI
- 1376633222NPI Registry (opens in a new tab)
- NPI enumeration date
- October 13, 2006
- NPI status
- Active
- Practice phone
- (206) 386-6000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 56
- Medical school graduation
- 1996
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. John Michael Pagel practices at Swedish Medical Center -First Hill in Seattle, Washington
Dr. Pagel's primary practice is Swedish Medical Center -First Hill, at 747 Broadway, Seattle, WA 98122 in King County. The practice phone is (206) 386-6000.
- Swedish Medical Center -First Hill747 Broadway, Seattle, WA 98122 · King CountyPhone(206) 386-6000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. John Michael Pagel is affiliated with 1 site of care
Dr. Pagel's primary practice is Swedish Medical Center -First Hill in Seattle, Washington.
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. John Michael Pagel's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pagel practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Swedish Medical Center -First Hill | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. John Michael Pagel is one of 348 hematologists and oncologists in Washington
Hematology and oncology is Dr. Pagel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Pagel is licensed in Washington.
Specialties and state licenses
- Hematology and oncology, WashingtonPrimary
Hematologists and oncologists near Dr. Pagel
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. John Michael Pagel billed Medicare for 413 services in 2021
CMS data shows 413 Medicare services from Dr. Pagel across 5 procedure codes in 2021. Medicare paid $32,388 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Pagel's Medicare services by type, 2020 to 2021
- 2020
- 2021
- Office and hospital visits
- 2020: 3652021: 3784%
- Other services
- 2020: 02021: 35
Dr. Pagel compared with the Washington median for hematologists and oncologists, 2021
- Dr. Pagel
- Washington median
- Medicare services
- 413vs 58529% below
- Part D claims
- 56vs 28380% below
Medians across 310 hematologists and oncologists in Washington with Dmand AI profiles that report each measure.
Dr. Pagel's most billed Medicare procedure codes, 2021
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Pagel?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Pagel and other hematologists and oncologists in Washington.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. John Michael Pagel's patients have a median age of 74
Across all payers, Dmand AI patient panel data puts Dr. Pagel's median patient age at 74, with 55% women.
Dr. Pagel's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women55%
- Men36%
Source: Dmand AI Patient Panel Data
Dr. John Michael Pagel wrote 56 Medicare Part D claims in 2022
In 2022, Dr. Pagel wrote 56 Medicare Part D claims. They cover 4 drugs, with $391,387 in total drug cost. In 2021, CMS named 698 claims across 20 drugs.
Dr. Pagel's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 6982022: 5692%
Drugs named by CMS: 4 in 2022, 20 in 2021.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. John Michael Pagel has 148 publications on record
Dmand AI links 148 papers to Dr. Pagel, published from 2002 to 2025. 2020 was the busiest year, with 18. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Leukemia, Lymphocytic, Chronic, B-Cell and Leukemia, Myeloid, Acute. Dr. Pagel has published most often in Blood. Dr. Pagel's most frequent co-authors are Ajay Kumar Gopal, Damian J. Green, MD and Mazyar Shadman, MD, MPH.
Dr. Pagel's papers by year, 2016 to 2025
Topics Dr. Pagel writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Myeloid, Acute
- Remission Induction
- Antibodies, Monoclonal
- Antineoplastic Agents
- Hematopoietic Stem Cell Transplantation
- Radioimmunotherapy
Dr. Pagel's most frequent co-authors
- Ajay Kumar Gopal38 shared papers
- Damian J. Green, MD28 shared papers
- Mazyar Shadman, MD, MPH22 shared papers
Recent publications by Dr. Pagel
See who Dr. Pagel researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Pagel works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. John Michael Pagel has worked on 7 clinical trials
Dmand AI links Dr. Pagel to 7 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell and Dendritic Cell Sarcoma, Interdigitating. Kite, A Gilead Company sponsors the most, 2.
Clinical trials with Dr. Pagel by phase
- 2Phase 1: 2 trials
- 1Phase 1/2: 1 trial
- 3Phase 2: 3 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Pagel's trials
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, B-Cell
- Dendritic Cell Sarcoma, Interdigitating
- Fever
- Leukemia, Lymphocytic, Chronic, B-Cell
Investigators on the most trials with Dr. Pagel
- Sven De Vos, MD2 shared trials
- Javier Luis Munoz, FACP, MD, MS2 shared trials
- Daniel Oscar Persky, MD2 shared trials
Recent clinical trials with Dr. Pagel
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL (opens in a new tab)
Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone in Multiple Myeloma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. John Michael Pagel received $1,537,881 in industry payments from 2016 to 2021
CMS Open Payments shows 1,485 general payments to Dr. Pagel from 26 drug and device companies from 2016 to 2021. Speaker and faculty fees make up the largest share, 62% of the total. AstraZeneca Pharmaceuticals LP paid the most, $399,591. It also lists 7 research payments totaling $4,930 from 2017 to 2021.
General payments to Dr. Pagel by program year, 2016 to 2021
General payments to Dr. Pagel by kind, 2016 to 2021
- Speaker and faculty fees$952,91362%
- Consulting fees$303,41320%
- Travel and lodging$206,45413%
- Honoraria$47,0563%
- Other$28,0442%
Companies that paid Dr. Pagel the most, 2016 to 2021
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. John Michael Pagel graduated from Boston University School of Medicine
Dr. Pagel graduated from Boston University School of Medicine in 1996.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. John Michael Pagel's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. John Michael Pagel
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. John Michael Pagel's NPI number?
Dr. John Michael Pagel's NPI number is 1376633222. It was assigned on October 13, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. John Michael Pagel?
Dr. John Michael Pagel is a hematologist and oncologist in Seattle, Washington. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. John Michael Pagel practice?
Dr. Pagel practices at 747 Broadway, Seattle, WA 98122. Dr. Pagel's primary practice is Swedish Medical Center -First Hill in Seattle, Washington.
What is Dr. John Michael Pagel's office phone number?
The practice phone on file for Dr. Pagel is (206) 386-6000.
What is Dr. John Michael Pagel's medical license number?
Dr. Pagel holds Washington license MD00037306.
Does Dr. John Michael Pagel accept Medicare?
Yes. CMS data shows Dr. Pagel billed Medicare for 413 services in 2021.
What services does Dr. John Michael Pagel bill to Medicare?
In 2021, Dr. Pagel's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and hospital inpatient care (99232).
Where did Dr. John Michael Pagel go to medical school?
Dr. Pagel graduated from Boston University School of Medicine in 1996.
What drugs does Dr. John Michael Pagel prescribe most?
In 2022 Medicare Part D data, Dr. Pagel's most prescribed drugs by claims were Acyclovir, Calquence and Venclexta.
Has Dr. John Michael Pagel received payments from drug or device companies?
CMS Open Payments shows $1,537,881 in general payments to Dr. Pagel from 26 companies from 2016 to 2021. The largest total came from AstraZeneca Pharmaceuticals LP.
Show 3 more questionsShow fewer questions
How long has Dr. John Michael Pagel been practicing?
Dr. Pagel graduated from medical school in 1996, 30 years ago.
Does Dr. John Michael Pagel do research?
Dmand AI links 148 publications to Dr. Pagel, published from 2002 to 2025. Dr. Pagel has worked on 7 clinical trials.
Who does Dr. John Michael Pagel publish with?
Dr. Pagel's most frequent co-authors are Ajay Kumar Gopal (38 shared papers), Damian J. Green, MD (28 shared papers) and Mazyar Shadman, MD, MPH (22 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Washington by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card